Andalusian Network for Design and Translation of Advanced Therapies Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2020
NCT04366245
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Andalusian Network for Design and Translation of Advanced Therapies